LAM closes $40M financing

LAM Therapeutics (Guilford, Conn.) said it raised $40 million in a venture round from undisclosed investors.

The company develops therapeutics for cancer and rare diseases. President and CSO Henri Lichenstein told BioCentury the company uses next-generation sequencing and computational platforms to repurpose existing molecules to treat new indications, in some cases via new delivery mechanisms. ...